RAPAd®

    The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

    Request Quote

    Confidentiality

     

    Learn More

    Quality Control

    Plaque forming units guarantee. Non-detectable RCA.

    Learn More

    Turnaround Time

    Sub-cloning to finished particles in about four weeks.

    Learn More

    Dual Expressers

    Multiple transgene expression in a single virus.

    Learn More

Tag Archives: Vaccine

Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus …

Authors: Martins MA, Shin YC, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Castro I, Magnani DM, Ricciardi M, Pedreño-Lopez N, Bailey V, Betancourt D, Altman JD, Pauthner M, Burton DR, von Bredow B, Evans DT, Yuan M, Parks CL, Ejima K, Allison DB, Rakasz E, Barber GN, Capuano S rd, Lifson JD, Desrosiers RC, Watkins DI.
Citation: PLoS Pathog. 2017 Jul 21;13(7):e1006529

read more

Cross-protective pathogen protection, methods and compositions thereof

Authors: John W. Schrader
Citation: Patent Application

read more

Age dependence of immunity induced by a candidate universal influenza vaccine in mice

Authors: García M, Misplon JA, Price GE, Lo CY, Epstein SL.
Citation: PLoS One. 2016 Apr 7;11(4):e0153195

read more

Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB

Authors: Kaveh DA, Garcia-Pelayo MC, Webb PR, Wooff EE, Bachy VS, Hogarth PJ
Citation: Vaccine. 2016 Jul 25;34(34):4003-11.

read more

Antibody-antigen kinetics constrain intracellular humoral immunity

Authors: Maria Bottermann, Heidrun Elisabeth Lode, Ruth E. Watkinson, Stian Foss, Inger Sandlie, Jan Terje Andersen,a, and Leo C. Jamesb,
Citation: Sci Rep. 2016; 6: 37457

read more

Vaccine-induced SIV-specific CD8+ T-cell responses focused on a single Nef epitope select for escape variants shortly after infection

Authors: Martins MA, Tully DC, Cruz MA, Power KA, Veloso de Santana MG, Bean DJ, Ogilvie CB, Gadgil R, Lima NS, Magnani DM, Ejima K, Allison DB, Piatak M Jr, Altman JD, Parks CL, Rakasz EG, Capuano S 3rd, Galler R, Bonaldo MC, Lifson JD, Allen TM, Watkins DI
Citation: J Virol. 2015 Nov;89(21):10802-20

read more

Vaccine-induced simian immunodeficiency virus-specific CD8+ T-cell responses focused on a single nef epitope select for escape variants shortly after infection

Authors: Martins MA, Tully DC, Cruz MA, Power KA, Veloso de Santana MG, Bean DJ, Ogilvie CB, Gadgil R, Lima NS, Magnani DM, Ejima K, Allison DB, Piatak M Jr, Altman JD, Parks CL, Rakasz EG, Capuano S 3rd, Galler R, Bonaldo MC, Lifson JD, Allen TM, Watkins DI
Citation: J Virol. 2015 Nov;89(21):10802-20

read more

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

Authors: Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP Jr, Jones FR, Schlom J
Citation: Oncotarget. 2015 Oct 13;6(31):31344-59

read more

A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform

Authors: Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, Beissert T, Bauer S, Hubich-Rau S, Tondera C, Eldin HS, Schmidt J, Vergara-Alert J, Süzer Y, Seifried J, Hanschmann KM, Kalinke U, Herold S, Sahin U, Cichutek K, Waibler Z, Eickmann M, Becker S, Mühlebach MD
Citation: J Virol. 2015 Nov;89(22):11654-67

read more